Moreover, the NAS was significantly decreased in EPA-treated MC4R-KO mice relative to control MC4R-KO mice, although the change in each NAS component (steatosis, inflammation, and ballooning degeneration) did not reach statistic significance (Fig 6E and 6F). Here, MC4R is linked to steatosis.